TAF Real World Study for Universal Effectiveness
NCT03752658
·
clinicaltrials.gov ↗
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis b
Interventions
DRUG:
Tenofovir Alafenamide
Sponsor
Tongji Hospital
Collaborators
[object Object]